Journal profile · MEDICINE, GENERAL & INTERNAL
Journal of Evidence Based Medicine
ISSN 1756-5383 · eISSN 1756-5391 · Wiley · Quarterly · Founded 2008
Journal of Evidence Based Medicine: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.61; hybrid open access; APC about USD 2,550; median 137 days to acceptance (96 articles, last 24 months); acceptance rate 18% (journal website); 112 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Evidence Based Medicine is published by Wiley and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Meta-analysis and systematic reviews, Lung Cancer Treatments and Mutations and Health Sciences Research and Education, together about 31.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Evidence-Based Medicine is the official English language journal of the Chinese Cochrane Centre. The journal aims to present the newest research results and promote the international understanding and development of evidence-based decision-making, research, practice, and education.Papers in any of the following fields will be considered: editorial, commentary, systematic review, clinical trial and register, methodology, policy-making and management, drug safety, education, patient safety, and knowledge translation. The journal encourages submissions from interdisciplinary studies and all manuscripts are blind peer-reviewed.
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, GENERAL & INTERNAL
Editor-in-chief You-Ping LiPublisher website
Editorial board by country: 29 in mainland China (about 35%); most named Mainland China 29, United States 13, United Kingdom 12, Germany 4, Canada 4 (83 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Meta-analysis and systematic reviewsDecision Sciences17.8%
- Lung Cancer Treatments and MutationsMedicine7.2%
- Health Sciences Research and EducationHealth Professions6.5%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance5.9%
- Clinical practice guidelines implementationMedicine5.5%
- Traditional Chinese Medicine StudiesMedicine5.2%
- Health Policy Implementation ScienceHealth Professions4.5%
- Lung Cancer Diagnosis and TreatmentMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, General & Internal | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, General & Internal | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, General & Internal | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCurrent ContentsPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.61LetPub ·
- Impact factor (publisher)
- 4.7Publisher website ·
- Impact factor (publisher) 2025
- 4.7Publisher website ·
- CiteScore 2026-06
- 4.6LetPub ·
- CiteScore (publisher)
- 4.6Publisher website ·
- CiteScore (publisher) 2025
- 4.6Publisher website ·
- SJR 2026-06
- 0.98LetPub ·
- SNIP 2026-06
- 1.39LetPub ·
- h-index
- 54OpenAlex ·
- i10-index
- 396OpenAlex ·
- 2-year mean citedness
- 3.13OpenAlex ·
- Self-citation rate
- 2.1%LetPub ·
- Share of gold OA articles
- 39.57%LetPub ·
Volume
- Articles per year
- 86LetPub ·
- Articles per year (publisher)
- 2Publisher website ·
- Articles per year (publisher) 2025
- 104Publisher website ·
- Downloads per year (publisher) 2025
- 260,425Publisher website ·
Articles by year OpenAlex count · 1,676 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 95 | 46 | 22 |
| 2025 | 112 | 70 | 328 |
| 2024 | 95 | 60 | 594 |
| 2023 | 74 | 48 | 691 |
| 2022 | 54 | 22 | 605 |
| 2021 | 45 | 14 | 858 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
137 daysMedian, submission to acceptance · P25–P75 92 days – 206 days
- Acceptance to online
- median 16 days (96 articles)
- Submission to online
- median 160 days
- Sample
- 96 articles with submission and acceptance dates (218 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher)
- 18%Publisher website ·
- Acceptance rate (publisher) 2025
- 18%Publisher website ·
- Submission to first decision
- 44 daysPublisher website ·
- Submission to first decision 2025
- 44 daysPublisher website ·
- Submission to acceptance 2025
- 143 daysPublisher website ·
- Acceptance to publication 2025
- 13 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,550 / EUR 2,100 / GBP 1,700 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Manuscript length
- ≤ 6,000 words
- Reference style
- Vancouver
- Cover letter
- Required
Article types accepted1
- editorialThe acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, ma…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Publication ethics, License & copyright
- AI use Large Language Models in Traditional Chinese Medicine: A Scoping Review
Yaxuan Ren, Xufei Luo, Ye Wang, Haodong Li, Hairong Zhang, Zeming Li, Honghao Lai, Xuanlin Li, Long Ge, Janne ESTILL, Lu Zhang, Shu Yang, Yaolong Chen, Chengping Wen, Zhaoxiang Bian, ADVANCED Working Group,
Source ↗Publisher website ·- Authorship Correction to authorship
In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, Journal of Evidence-Based Medicine will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To re…
Source ↗Publisher website ·- Publication ethics ETHICAL CONSIDERATIONS
Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki (as revised in Brazil in 2013), available at http://www.wma.net/en/30publications/10policies/b3/17c.pdf.
Source ↗Publisher website ·- License & copyright COPYRIGHT AND LICENSING
Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley
- Language
- English
- Frequency
- Quarterly
- Founded
- 2008
- ISSN
- 1756-5383
- Electronic ISSN
- 1756-5391
- Latest issue on the website
- Volume 19, Issue 2 (June 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Evidence Based Medicine
What CAS zone is Journal of Evidence Based Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Evidence Based Medicine is in Zone 2 of Medicine, and in Zone 2 of the minor category Medicine, General & Internal. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Evidence Based Medicine?
The latest impact factor listed by LetPub is 4.61; CiteScore 4.6, h-index 54.
How long does peer review take at Journal of Evidence Based Medicine?
Based on the dates recorded on 96 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 137 days (interquartile range 92–206 days); the journal's website gives an acceptance rate of 18% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Evidence Based Medicine?
According to the journal's author guidelines: Manuscript length: ≤ 6,000 words; Reference style: Vancouver; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Evidence Based Medicine based?
Of the 83 board members whose country the journal's board page names, 29 (about 35%) are in mainland China; the countries named most often are Mainland China (29), United States (13) and United Kingdom (12). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Evidence Based Medicine?
According to LetPub and DOAJ records, Journal of Evidence Based Medicine is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase and Current Contents; that list has not been checked against each database.
Is Journal of Evidence Based Medicine open access, and what is the APC?
Journal of Evidence Based Medicine is a hybrid journal. For open-access publication: APC about USD 2,550.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .